The ovarian cancer cell lines modestly recapitulate the spectrum of mutations found in primary ovarian tumors. The ovarian cancer cell lines modestly recapitulate.

Slides:



Advertisements
Similar presentations
Bioinformatics lectures at Rice University Li Zhang Lecture 10: Networks and integrative genomic analysis-2 Genome instability and DNA copy number data.
Advertisements

By: Katie Adolphsen, Robin Aldrich, Brandon Hu, Nate Havko.
PIK3CA gene amplification in glioblastoma and squamous cell carcinoma (SCC) of the lung. PIK3CA gene amplification in glioblastoma and squamous cell carcinoma.
Homozygous deletions within chromosome 9q23.
KDM1B Expression in Richardson Breast 2
Genes with Bimodal Expression Are Robust Diagnostic Targets that Define Distinct Subtypes of Epithelial Ovarian Cancer with Different Overall Survival 
The cBio Cancer Genomics Portal.
Fig. 8. Recurrent copy number amplification of BRD4 gene was observed across common cancers. Recurrent copy number amplification of BRD4 gene was observed.
Strategy Description Discovery Validation Application
Assessing Copy Number Alterations in Targeted, Amplicon-Based Next-Generation Sequencing Data  Catherine Grasso, Timothy Butler, Katherine Rhodes, Michael.
CDKN2A/p16 Inactivation Mechanisms and Their Relationship to Smoke Exposure and Molecular Features in Non–Small-Cell Lung Cancer  Kit W. Tam, MD, MHS,
Comprehensive Screening of Gene Copy Number Aberrations in Formalin-Fixed, Paraffin-Embedded Solid Tumors Using Molecular Inversion Probe–Based Single-
Frequency of JAK1 and JAK2 alterations and their association with overall survival in TCGA datasets. Frequency of JAK1 and JAK2 alterations and their association.
Prognostic significance of DDB2 in ovarian cancer.
Volume 17, Issue 1, Pages (January 2010)
WES detects a limited number of clinically targetable alterations in patients with advanced cancer. WES detects a limited number of clinically targetable.
Genomic alterations in breast cancer cell line MDA-MB-231.
Mutational burden of somatic, protein-altering mutations per subject from WES for patients with advanced colon cancer who participated in PD-1 blockade.
Integrative Genomic Profiling of Human Prostate Cancer
A Tumor Sorting Protocol that Enables Enrichment of Pancreatic Adenocarcinoma Cells and Facilitation of Genetic Analyses  Zachary S. Boyd, Rajiv Raja,
Intrinsic and acquired trastuzumab resistance.
Copy-number alterations in an archival breast cancer sample.
Ovarian cancer cells harbour numerous copy number alterations unlinked to drug‐induced cell death Ovarian cancer cells harbour numerous copy number alterations.
AKT dependence of ovarian cancer cell lines.
Volume 29, Issue 5, Pages (May 2016)
Identification of TLOC1 and SKIL as tumor driver genes in 3q26.
Cyclin E1 Is Amplified and Overexpressed in Osteosarcoma
Reversing the TERT promoter mutation to WT reverses the active chromatin marks and alters long-range chromatin interactions. Reversing the TERT promoter.
Volume 25, Issue 5, Pages e5 (October 2018)
Patterns of Somatically Acquired Amplifications and Deletions in Apparently Normal Tissues of Ovarian Cancer Patients  Leila Aghili, Jasmine Foo, James.
Identification and characterization of a novel KRAS rearrangement in metastatic prostate cancer. Identification and characterization of a novel KRAS rearrangement.
Image analysis and HER-2/neu slide scoring.
Patterns of Somatically Acquired Amplifications and Deletions in Apparently Normal Tissues of Ovarian Cancer Patients  Leila Aghili, Jasmine Foo, James.
High-level clonal amplification of FGFR2 predicts for sensitivity to FGFR inhibitor. High-level clonal amplification of FGFR2 predicts for sensitivity.
NRG1 rearrangements are found in multiple solid tumors.
EZH2 overexpression establishes a unique and conserved super-enhancer–associated transcriptional landscape. EZH2 overexpression establishes a unique and.
A, unsupervised hierarchical clustering of the expression of probe sets differentially expressed in the oral mucosa of smokers versus never smokers. A,
Integrated mRNA and microRNA expression and DNA methylation clusters.
Heat map of genes for which CR significantly altered expression versus AL. Cluster analysis of genes significantly changed by the CR intervention compared.
CHCHD2 and EGFR protein expression in NSCLC
Relationship between the expression of immune-related genes and burdens of somatic mutation. Relationship between the expression of immune-related genes.
Targetable alterations and pathways in TNBCs after NAC
Radiation does not alter AKT and MTOR gene expression.
MPM cases with GNH. A, WES-based LOH profiling with the FACETS algorithm revealed three MPM samples with genome-wide LOH. B, Allelic copy-number plots.
CREBBP loss-of-function results in gene expression repression signature. CREBBP loss-of-function results in gene expression repression signature. A–D,
PD-L1 is expressed in breast cancer.
Reduced number and impaired effector functions of TILs in tumors with PTEN deletion or loss-of-function mutations in PTEN. Cutaneous melanoma patients.
A and B, two blocks from the original specimen used for TMA demonstrated areas with varying patterns of ALK rearrangement and KRAS mutation status. A and.
Identification of general and tissue-specific essential genes.
Frequently mutated genes in colorectal cancer.
Global mutational landscape of the 170 lung adenocarcinoma patients (discovery cohort). Global mutational landscape of the 170 lung adenocarcinoma patients.
Concordance between the genomic landscape identified by whole-exome sequencing of plasma cfDNA and tumor; DNA and recurrence of KDR/VEGFR2 oncogenic mutations.
Single nucleotide polymorphism array analysis can distinguish different genetic mechanisms that lead to loss of heterozygosity (LOH). Single nucleotide.
Landscape of genomic alterations identified by WES in biopsies of patients with advanced PDAC. Co-mutation plot displaying integrated genomic data for.
Germline variants influencing primary tumor type.
A, heatmap of copy number alterations determined by array CGH for a panel of 79 frozen NSCLC samples. A, heatmap of copy number alterations determined.
PIK3CA somatic mutation and amplification frequency in prostate cancer
Correlations between APOBEC expression and immune cell markers across 22 cancer types. Correlations between APOBEC expression and immune cell markers across.
Mutational signature analysis of WES data from patients with advanced PDAC. A, Projection of signatures representing four main mutational processes identified.
EZH2-driven lung cancer as a molecularly distinct entity.
Detection of BRCA reversion mutations in pretreatment cfDNA and tumor biopsy. Detection of BRCA reversion mutations in pretreatment cfDNA and tumor biopsy.
Superenhancers near the KLF5 gene are focally amplified in diverse cancer types. Superenhancers near the KLF5 gene are focally amplified in diverse cancer.
PTEN genotype frequently dictates PTEN expression status, but evidence of heterogeneous staining implies polyclonality within some ovarian tumors. PTEN.
Driver pathways and key genes in OSCC
CASP8 mutations are associated with fewer CNAs and RAS family mutations. CASP8 mutations are associated with fewer CNAs and RAS family mutations. A, number.
Genomic instability is a core feature of ovarian cancer that frequently involves DNA-damage repair genes. Genomic instability is a core feature of ovarian.
Genomic and proteomic profiling of ovarian cancer cell lines.
Molecular characterization of esophagogastric tumors.
TME characteristics of TCGA-STAD subtype and cancer somatic genome.
Synthetic lethality of ROS1 inhibition in E-cadherin–deficient breast tumor cell lines. Synthetic lethality of ROS1 inhibition in E-cadherin–deficient.
Presentation transcript:

The ovarian cancer cell lines modestly recapitulate the spectrum of mutations found in primary ovarian tumors. The ovarian cancer cell lines modestly recapitulate the spectrum of mutations found in primary ovarian tumors. A, heat map showing the concordance of PI3K and RAS pathway alterations and RB1 deletions/mutations for 316 serous ovarian cancer TCGA samples. Amplifications are indicated in solid red, homozygous deletions in solid blue, and somatic mutations in green. Overexpression of AKT3 is indicated by a hollow, red rectangle. B, log2 mRNA expression was assessed as a function of GISTIC-based DNA copy number calls (homozygous deletion, hemizygous loss, diploid, gain, high-level amplification) across all samples. P values were generated using analysis of variances. The red line in the AKT3 box plot indicates the cutoff for samples with significant mRNA overexpression (red “x”) as defined by > 2 standard deviations of the mean of the samples that are diploid/copy-neutral for AKT3. C, copy number heat maps demonstrating the focality of the amplifications encompassing the KRAS, PIK3CA, and AKT3 loci. X-axis illustrates the copy number status (red: amplification, white: copy neutral, blue: deletion) of the indicated gene for each of the 316 TCGA samples listed on y-axis. Aphrothiti J. Hanrahan et al. Cancer Discov 2012;2:56-67 ©2012 by American Association for Cancer Research